EUVIMEDEUVIMED entdecken
Crossref

Could fructosamine be used in the glycemic monitoring of individuals with a history of gestational diabetes mellitus?

Christos Chatzakis, Tanvi Mansukhani, Rea Mitsigiorgi, Elodie May, Kypros H Nicolaides

Diabetes & Metabolic Syndrome: Clinical Research & Reviews · 2026-05 · 20 (5) · 103440

DOI: 10.1016/j.dsx.2026.103440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2026-05. Verfasst von Christos Chatzakis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fetal Medicine Research Institute, King's College Hospital, London, United Kingdom. Hauptthemen laut MEDLINE: Fructosamine, Diabetes, Gestational, Diabetes Mellitus, Type 2, Biomarkers. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Fetal Medicine Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: To evaluate the association of fructosamine with multiple glycemic control indices in individuals with previous gestational diabetes mellitus(GDM), with or without prediabetes or type 2 diabetes(T2D). MATERIALS: Individuals with prior GDM were studied 5-9 months postpartum. Data included demographics, medical history, clinical measures, HbA1c, oral glucose tolerance test(OGTT), fructosamine, and blinded continuous glucose monitoring(CGM). Associations between fructosamine and glycemic indices were assessed using regression models with interaction terms for dysglycemia; standardized models and partial R2 enabled head-to-head comparison with HbA1c. RESULTS: Among 844 participants, 407(48.2%) had prediabetes and 47(5.5%) T2D. Mean fructosamine was higher in T2D(255.6 ± 4.0 μmol/L) than in normoglycemic (235.7 ± 22.0 μmol/L) and prediabetes groups(238.3 ± 21.4; p < 0.001). Fructosamine correlated with 2-h post-load glucose(β = 0.018,p < 0.001) and HbA1c(β = 0.054,p < 0.001), but not fasting glucose; it was inversely related to CGM time-in-range and positively to time-above-range, time-below-range, glucose management indicator, glycemic variability, and coefficient of variation. Associations were strongest in T2D. Compared directly, HbA1c related more to time-in-range, whereas fructosamine more strongly reflected glycemic variability. Combined models improved fit. CONCLUSIONS: In individuals with prior GDM, fructosamine captured adverse glycemic patterns, especially variability and provided information complementary to HbA1c, supporting its use as a practical adjunct where CGM is unavailable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FructosamineDiabetes, GestationalDiabetes Mellitus, Type 2BiomarkersPrediabetic StateHumansFemalePregnancyAdultContinuous Glucose MonitoringBlood GlucoseGlycated HemoglobinFollow-Up StudiesPrognosisGlucose Tolerance TestGlycemic Control

Stichwörter der Autor:innen

Continuous glucose monitoringDiabetesFructosamineGestational diabetes mellitus: prediabetesGlycosylated haemoglobin

Substanzen

FructosamineBlood GlucoseGlycated HemoglobinBiomarkershemoglobin A1c protein, human

Autor:innen und Institutionen

  • Fetal Medicine Research Institute, King's College Hospital, London, United Kingdom.
  • Fetal Medicine Research Institute, King's College Hospital, London, United Kingdom. Electronic address: kypros@fetalmedicine.com.

Förderung

  • Fetal Medicine Foundation

Zitieren

APA

Chatzakis, C., Mansukhani, T., Mitsigiorgi, R., May, E., & Nicolaides, K. H. (2026). Could fructosamine be used in the glycemic monitoring of individuals with a history of gestational diabetes mellitus?. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 20(5), 103440. https://doi.org/10.1016/j.dsx.2026.103440

Vancouver

Chatzakis C, Mansukhani T, Mitsigiorgi R, May E, Nicolaides KH. Could fructosamine be used in the glycemic monitoring of individuals with a history of gestational diabetes mellitus?. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2026;20(5):103440. doi:10.1016/j.dsx.2026.103440

BibTeX
@article{Chatzakis2026,
  author = {Chatzakis, Christos and Mansukhani, Tanvi and Mitsigiorgi, Rea and May, Elodie and Nicolaides, Kypros H},
  title = {Could fructosamine be used in the glycemic monitoring of individuals with a history of gestational diabetes mellitus?},
  journal = {Diabetes & Metabolic Syndrome: Clinical Research & Reviews},
  year = {2026},
  volume = {20},
  number = {5},
  pages = {103440},
  doi = {10.1016/j.dsx.2026.103440}
}
Kostenlos starten →